Revision history of "Modification of signaling pathways of canine Th17 lymphocytes subset to improve Adoptive cellular immunotherapy for humans" (Q84267)

13 October 2024

• curprev 06:2006:20, 13 October 2024‎ DG Regio talk contribs‎ 65,856 bytes +3‎ ‎Changed label, description and/or aliases in pt
• curprev 06:2006:20, 13 October 2024‎ DG Regio talk contribs‎ 65,853 bytes +26‎ ‎Set a claim value: summary (P836): A imunoterapia por transferência celular adotiva (ACT) é considerada o tratamento mais promissor do cancro; no entanto, continua a ser limitada pela utilização de células T de curta duração e esgotadas. Recentemente, os linfócitos T CD4+ produtores de IL-17 (células Th17) mostraram-se superiores na erradicação do melanoma em camundongos em comparação com as células Th1. Propomos determinar o protocolo ex vivo de expansão de células Th17 de cães domé...

22 March 2024

• curprev 12:1412:14, 22 March 2024‎ DG Regio talk contribs‎ 65,827 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.8423142846446687

6 July 2023

• curprev 11:3311:33, 6 July 2023‎ DG Regio talk contribs‎ 65,539 bytes 0‎ ‎Changed an Item
• curprev 08:4508:45, 6 July 2023‎ DG Regio talk contribs‎ 65,539 bytes 0‎ ‎Changed an Item

11 June 2023

• curprev 11:1311:13, 11 June 2023‎ Admin talk contribs‎ 65,539 bytes +435‎ BatchIngestion

24 May 2023

• curprev 17:1117:11, 24 May 2023‎ DG Regio talk contribs‎ 65,104 bytes +949‎ ‎Changed an Item

2 March 2023

• curprev 23:4623:46, 2 March 2023‎ DG Regio talk contribs‎ 64,155 bytes +44‎ ‎Changed label, description and/or aliases in cs, da, mt, sl, lv, lt, es, fr, sk, et, fi, nl, sv, bg, ro, el, hr, de, hu, and other parts

25 October 2022

• curprev 14:2914:29, 25 October 2022‎ DG Regio talk contribs‎ 64,111 bytes +1,289‎ ‎Changed an Item: Import item from Poland

21 October 2022

• curprev 10:5010:50, 21 October 2022‎ DG Regio talk contribs‎ 62,822 bytes +1,211‎ ‎Changed an Item: Import item from Poland
• curprev 10:5010:50, 21 October 2022‎ DG Regio talk contribs‎ 61,611 bytes −419‎ ‎Removed claim: co-financing rate (P837): 100.0 percentage

26 July 2022

• curprev 03:4303:43, 26 July 2022‎ DG Regio talk contribs‎ 62,030 bytes +38,873‎ ‎Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

• curprev 12:4812:48, 19 January 2022‎ DG Regio talk contribs‎ 23,157 bytes +2,227‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

15 January 2022

• curprev 23:2423:24, 15 January 2022‎ DG Regio talk contribs‎ 20,930 bytes +2,136‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

16 December 2021

• curprev 19:5819:58, 16 December 2021‎ DG Regio talk contribs‎ 18,794 bytes +2,150‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

7 December 2021

• curprev 09:1309:13, 7 December 2021‎ DG Regio talk contribs‎ 16,644 bytes +2,132‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

30 November 2021

• curprev 16:2416:24, 30 November 2021‎ DG Regio talk contribs‎ 14,512 bytes +2,080‎ ‎Created claim: summary (P836): L’immunothérapie par transfert de cellules adoptives (ACT) est considérée comme le traitement le plus prometteur du cancer; cependant, il est encore limité par l’utilisation de cellules T de courte durée et épuisées. Récemment, l’IL-17 produisant des lymphocytes CD4+ T (cellules Th17) s’est avéré supérieur dans l’éradication du mélanome chez la souris par rapport aux cellules Th1. Nous proposons de déterminer le protocole ex vivo en expansion de...
• curprev 16:2416:24, 30 November 2021‎ DG Regio talk contribs‎ 12,432 bytes +217‎ ‎Changed label, description and/or aliases in fr: translated_label

29 October 2020

• curprev 05:2305:23, 29 October 2020‎ DG Regio talk contribs‎ 12,215 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 05:2305:23, 29 October 2020‎ DG Regio talk contribs‎ 12,621 bytes −34‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

14 October 2020

• curprev 12:3412:34, 14 October 2020‎ DG Regio talk contribs‎ 12,655 bytes +182‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 12:3412:34, 14 October 2020‎ DG Regio talk contribs‎ 12,473 bytes −158‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label
• curprev 12:3412:34, 14 October 2020‎ DG Regio talk contribs‎ 12,631 bytes +1,816‎ ‎Created claim: summary (P836): Adoptive cell transfer (ACT) immunotherapy is considered the most promising treatment of cancer; however it is still limited by the use of short-lived and exhausted T cells. Recently, IL-17 producing CD4+ T lymphocytes (Th17 cells) have been shown to be superior in eradication of melanoma in mouse compared to Th1 cells. We propose to determine the expanding ex vivo protocol of Th17 cells from domestic dog in order to support comparative oncology...
• curprev 12:3412:34, 14 October 2020‎ DG Regio talk contribs‎ 10,815 bytes −1,106‎ ‎Removed claim: summary (P836): (ACT) immunotherapie is recognised the most Promisised treatment of cancer;h it is still limited by the use of short and open T cells.Recentric, IL-17 producing CD4 + T lympcytes (Th17 celels) have been shown to be superimor in operation of molasses in mouse comed to Th1 cells.To justify this determine the exating ex vivo protocol of Th17 cells from domestic provision in order to support comparative therapeutic research and improvements to the...

9 June 2020

• curprev 18:5718:57, 9 June 2020‎ DG Regio talk contribs‎ 11,921 bytes +429‎ ‎Changed an Item

7 June 2020

• curprev 10:1410:14, 7 June 2020‎ DG Regio talk contribs‎ 11,492 bytes +431‎ ‎Changed an Item

26 March 2020

• curprev 13:4613:46, 26 March 2020‎ DG Regio talk contribs‎ 11,061 bytes +431‎ ‎Changed an Item

4 March 2020

• curprev 10:0210:02, 4 March 2020‎ DG Regio talk contribs‎ 10,630 bytes +1,106‎ ‎Created claim: summary (P836): (ACT) immunotherapie is recognised the most Promisised treatment of cancer;h it is still limited by the use of short and open T cells.Recentric, IL-17 producing CD4 + T lympcytes (Th17 celels) have been shown to be superimor in operation of molasses in mouse comed to Th1 cells.To justify this determine the exating ex vivo protocol of Th17 cells from domestic provision in order to support comparative therapeutic research and improvements to the A...

18 February 2020

• curprev 07:4707:47, 18 February 2020‎ DG Regio talk contribs‎ 9,524 bytes +158‎ ‎Changed an Item: Label in wikidata changed

8 February 2020

• curprev 18:5418:54, 8 February 2020‎ DG Regio talk contribs‎ 9,366 bytes +823‎ ‎Changed an Item
• curprev 18:5418:54, 8 February 2020‎ DG Regio talk contribs‎ 8,543 bytes −417‎ ‎Removed claim: financed by (P890): European Union (Q1)

31 January 2020

• curprev 10:5110:51, 31 January 2020‎ DG Regio talk contribs‎ 8,960 bytes +844‎ ‎Changed an Item

14 January 2020

• curprev 10:2810:28, 14 January 2020‎ DG Regio talk contribs‎ 8,116 bytes +8,116‎ ‎Created a new Item